Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The Cancer Worry Scale was revised to be used in breast cancer genetic counseling (CWS-GC). This scale is used to identify dimensions that are relevant in the genetic counseling context, such as worry about developing breast cancer, impact of worries on daily life, and risk perception in women attending a counseling session for BRCA1/2 mutations.
Objective: The aim of this study was to estimate the psychometric properties of the CWS-GC in a sample of Italian women.
Methods: A total of 304 women aged 19 to 90 years, 58% with history and 42% with no history of breast or ovarian cancer, participated in the study. Validity, reliability, and sensitivity to change of the CWS-GC were assessed.
Results: Confirmatory factor analysis suggested a 2-factor structure of the CWS-GC measuring cancer worry and risk perception and with Cronbach's α coefficients of .90 and .70, respectively. Criterion validity was attested by substantial yet not overlapping correlations with anxiety and fear of medical procedures. In a subsample of 50 women, test-retest reliability at a 4-week interval ranged from 0.70 to 0.87, and the CWS-GC was able to detect small to medium changes 1 month after genetic counseling.
Conclusions: Overall, the CWS-GC showed good psychometric characteristics in this population.
Implications For Practice: The CWS-GC would be appropriate for use by healthcare professionals to better understand how women react and adapt to information on genetic cancer risk to provide them with emotional support and encourage surveillance behaviors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/NCC.0000000000000511 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Psychological distress in Chinese women with benign breast disease and breast cancer during diagnosis: A cross-sectional study.
Adv Clin Exp Med
September 2025
Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Background: Research on the psychological distress experienced by women with benign breast disease (BBD) remains limited, though some evidence suggests it may resemble that of women with breast cancer (BC).
Objectives: This study aimed to use the Distress Thermometer (DT) to assess the levels of psychological distress and identify influencing factors during the diagnostic phase in patients with BC and BBD.
Material And Methods: From October 2022 to May 2023, a questionnaire survey incorporating the DT and Problem List (PL) was conducted among inpatients in the diagnostic phase for BC or BBD at the Breast Surgery Department of Shanxi Bethune Hospital (Taiyuan, China).
Mammographic Breast Pseudocalcifications Associated With Topical Betamethasone Dipropionate.
Eur J Breast Health
September 2025
University of Miami Hospital, Department of Radiology, Division of Breast Imaging, Miami, USA.
Screening mammography plays a critical role in the early detection of breast cancer. Suspicious breast calcifications on mammography often prompt further diagnostic evaluation due to concern for malignancy, worrying physicians and patients alike. Here, we present a case of a woman in her 70s whose annual screening mammogram with digital breast tomosynthesis demonstrated two new groups of microcalcifications, confirmed after recall with magnification views.
View Article and Find Full Text PDFAssociation of cancer with racial disparities in financial health: a national cohort study.
Support Care Cancer
September 2025
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Purpose: The impact of a cancer diagnosis on racial differences in financial well-being and treatment related financial toxicity has not been well characterized. The purpose of this study was to compare relative disparities in financial distress by race among respondents with and without a history of cancer.
Methods: We performed a retrospective cohort study based on the National Health Interview Survey (2010 to 2018).
Managing, not lessening, uncertainty: a novel mind-body intervention for fear of cancer recurrence.
J Cancer Surviv
September 2025
Massachusetts General Hospital, 100 Cambridge St., 16Th Floor, Boston, MA, 02114, USA.
Purpose: After a cancer diagnosis, uncertainty is common. IN FOCUS is a pilot randomized controlled trial that evaluated the feasibility and acceptability of a virtual mind-body group resiliency intervention on fear of cancer recurrence (FCR). The current study examines secondary outcomes of this trial, specifically exploring changes in related mental health constructs, which will contribute to our understanding of symptom relief as well as diagnostic overlap and discrepancies.
View Article and Find Full Text PDFDecision-making experience for second donation in unrelated hematopoietic stem cell donors: a descriptive qualitative study.
J Cancer Surviv
August 2025
Hematology Department, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Background: A second allogeneic hematopoietic stem cell transplantation (allo-HSCT) is often the most effective treatment option for patients experiencing graft failure or disease relapse following a first round of allo-HSCT. Unfortunately, the consent rate for second donation is insufficient to meet treatment needs worldwide. The purpose of this study was to provide a comprehensive understanding of the decision-making experience of unrelated donors when considering making a second donation.
View Article and Find Full Text PDF